PBS lists first new endometriosis treatment in 30 years
Dienogest is the first new treatment listed on the PBS in 30 years.
Progestogen drug Visanne (dienogest 2mg) has been listed on the PBS for endometriosis, cutting the monthly cost from around $70 to $31.60 for non-concessional patients.
As the first new PBS listing for endometriosis since nafarelin (Synarel) in 1994, the move was “life-changing” for patients, said Melbourne GP Associate Professor Magdalena Simonis.
“It’s also going to be life-changing for GPs,” Professor Simonis told AusDoc.
“We’re going to be able to help a lot more of our patients and take the load off the hospital system by cutting down laparoscopies.”
